<?xml version="1.0" encoding="UTF-8"?>
<p id="Par19">Faced with the human being fragility in relation to the severity of some infectious diseases that prove to be a worldwide public health problem, the current scenario in which the planet finds itself sparing no effort in order to face a pandemic or even in the fight against resistant microorganisms, considering the new formulations development essential. In light of this, the drugs association with promising nanocarriers such as MSNs is fundamental to achieve new smart nanotherapeutics systems for all aforementioned diseases (
 <xref ref-type="bibr" rid="CR12">12</xref>,
 <xref ref-type="bibr" rid="CR20">20</xref>,
 <xref ref-type="bibr" rid="CR58">58</xref>â€“
 <xref ref-type="bibr" rid="CR60">60</xref>).
</p>
